CXCR4 Chemokine Receptor Antagonists from Ultra-rigid Metal Complexes Profoundly Inhibit HIV-1 Replication, and also AMD3100-resistant Strains

Stephen J. Archibald; Dirk Daelemans; Timothy J. Hubin; Dana Huskens; Dominique Schols; Kristel Van Laethem; De Clercq Erik; Christophe Pannecouque

doi:10.1016/j.antiviral.2009.02.100

Related publications

Article2009

Binding Optimization through Coordination Chemistry: CXCR4 Chemokine Receptor Antagonists from Ultrarigid Metal Complexes

Abid Khan, Gary Nicholson, John Greenman, Leigh A. Madden, Graeme McRobbie, Christophe Pannecouque, De Clercq Erik, Robert Ullom, D.L. Maples, Randall D. Maples, J.D. Silversides, Timothy J. Hubin, Stephen J. Archibald

Article1999

Bicyclams, Selective Antagonists of the Human Chemokine Receptor CXCR4, Potently Inhibit Feline Immunodeficiency Virus Replication

Herman Egberink, De Clercq Erik, Arno L. W. van Vliet, Jan Balzarini, Gary Bridger, Geoffrey Henson, Marian C. Horzinek, Dominique Schols

Article2001

Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.

De Clercq Erik, Dominique Schols

Article2012

CXCR4 chemokine receptor antagonists: nickel(ii) complexes of configurationally restricted macrocycles

Rachel Smith, Dana Huskens, Dirk Daelemans, Ryan E. Mewis, Courtney D. Garcia, Amy N. Cain, TaRynn N. Carder Freeman, Christophe Pannecouque, De Clercq Erik, Dominique Schols, Timothy J. Hubin, Stephen J. Archibald

Article2003

Reduced Fitness of HIV-1 Resistant to Cxcr4 Antagonists

Mercedes Armand‐Ugón, Miguel E. Quiñones‐Mateu, Arantxa Gutiérrez, Jordi Barretina, Julià Blanco, Dominique Schols, De Clercq Erik, Bonaventura Clotet, José A. Esté